AABP Executive Director Dr. Fred Gingrich is joined by three AABP members on this episode of Have You Herd? where we discuss decision-making for utilizing extra-label drug use, working with producers for ensuring appropriate oversight of antimicrobial use, and utilizing resources from the Food Animal Avoidance Residue Avoidance Databank (FARAD). The three guests are current AABP Committee on Pharmaceutical and Biologic Issues members including Chair, Dr. Kevin Jacque from The Ohio State University, Dr. Virginia Fajt from Texas A&M University and Dr. Fiona Maunsell from the University of Florida and FARAD. 

We start the conversation by discussing considerations for extra-label drug use in cattle, including the different production classes of beef and dairy cattle that should be considered and how this use may affect the determination of a withdrawal interval. The veterinarian of record is the party responsible for ensuring appropriate oversight of drug use and assigning that withdrawal interval, and our guests discuss that veterinarians should take pride in being responsible for extra-label drug use. Dr. Maunsell discusses the FARAD program, where it receives its funding and the fact it is an advisory, not regulatory, program. We discuss how veterinarians can improve the accuracy of information received from FARAD by filling out their online submission entirely and accurately. The group also discusses inadvertent prohibited drug use and how to communicate with FARAD to assign a withdrawal time as well as working with clients to ensure we correct the errors that led to the inadvertent use. 

 LINKS:

 Extra-label drug use regulations:
https://www.ecfr.gov/current/title-21/chapter-I/subchapter-E/part-530

Definition of food-producing animals:
https://www.fda.gov/media/70157/download (see p. 29)

Food Animal Residue Avoidance Databank:
http://www.farad.org/

AABP VCPR Guidelines:
https://aabp.org/resources/aabp_guidelines/VCPRGuideline_032020.pdf

AABP Antimicrobial Stewardship Guidelines:
https://aabp.org/resources/AABP_Guidelines/AntimicrobialStewardship0322Final.pdf